Hikma Pharmaceuticals Announces Director/PDMR Shareholding
Why we think this is neutral
This RNS announcement is related to a director/PDMR shareholding change, which is a routine regulatory disclosure and does not contain any significant business updates or financial information.
Key Points
- Bassam Kanaan, a PDMR, has disposed of 40,000 ordinary shares in Hikma Pharmaceuticals PLC
- The shares were sold at a price of £21.05 per share
Summary
The pharmaceutical company has disclosed a transaction by a Person Discharging Managerial Responsibilities.
Hikma Pharmaceuticals PLC (LSE: HIK) has announced a transaction by a Person Discharging Managerial Responsibilities (PDMR) of the company. The PDMR, Bassam Kanaan, has disposed of 40,000 ordinary shares in Hikma Pharmaceuticals PLC at a price of £21.05 per share.
DIRECTOR DEALINGS